CClinicalTrials.gg
Status unknownNCT03751696Updated Apr 20, 2021

Coaching Intervention in Women At-risk of Common Mental Disorders

An interventional study of Group Coaching and SMS self-help tips in Common Mental Disorder, sponsored by The University of Hong Kong. Status unknown at 1 site in Hong Kong. Open to female participants aged 18 Years to 64 Years. Per ClinicalTrials.gov, last updated 2021-04-20.

Sponsored by The University of Hong Kong · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Apr 2021), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 64 Years
Sex
Female
01

Study summary

This study aims to provide preventative intervention to 60 women who are at risk of common mental disorders in Hong Kong.

Read the detailed description

Participants will be recruited through the following routes: 1) by our partner non-governmental organizations, 2) by our research team through community outreach or training activities, 3) online screening tool, and 4) referral from organizations that provide service to women (e.g., Maternal and Child Health Clinics of Department of Health). Eligible subjects with informed consent provided will be randomly assigned to coaching group or SMS self-help tips. To test the effectiveness of the provided intervention programs, symptoms assessments and data collection on demographics and psychosocial data will be carried out during baseline, immediately, and 3 months post-intervention.

02

Conditions studied

  • Common Mental Disorder
03

In context

Mental Disorders

2,107 studies on the registry are indexed under Mental Disorders; 416 are open to participants now.

This study's planned enrollment of 60 is below the median of 94 across 1,574 interventional studies indexed under Mental Disorders.

Browse Mental Disorders studies →

Lead sponsor

The University of Hong Kong is the lead sponsor of 1,262 studies on the registry; 340 are open to participants now.

Of its 8 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 64 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Willing to provide written informed consent
  • Able to understand Cantonese and read/write Chinese
  • With subsyndromal or minor depressive symptoms indicated by
  • Depression subscale of Depression, Anxiety and Stress Scale (DASS) score 10-20 or
  • Edinburgh Postnatal Depression Scale (EPDS) scores 10-13

Exclusion criteria

Exclusion Criteria:

  • A positive response in items about suicidal thoughts if applicable ("Yes, quite often" and "sometimes" in EPDS) (These participants will be referred to suicidal management)
  • Those mental conditions that require other treatment priorities (e.g., suicidal risk, substance abuse, current or past episodes of psychotic disorder, personality disorders)
  • Those medical conditions that severely limit participation, comprehension, or adherence to treatment (e.g., epilepsy, dementia, terminal medical illness)
  • Those who are receiving structured psychotherapy or counseling
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Group coaching

    There will be a total of 4 sessions of group coaching intervention within 8 weeks. Each session is in a group of 5-6 women and lasts for approximately 1-1.5 hours. The sessions will be conducted by experienced social workers online.

    Behavioral: Group Coaching

  • Active comparator
    SMS Self-help tips

    The participants in the control group will receive four self-help tips on mental well-being on the same schedule as the group coaching group.

    Behavioral: SMS self-help tips

Interventions

  • BehavioralGroup Coaching

    4 sessions of 1-1.5-hour group coaching intervention within 8 weeks

  • BehavioralSMS self-help tips

    4 mental well-being tips through sms within 8 weeks

06

What researchers measure

Primary outcomes

  1. Depressive symptoms

    Measured by the depression subscale of the Depression, Anxiety and Stress Scale

    Time frame: immediate post-intervention

  2. Anxiety symptoms

    Measured by the anxiety subscale of the Depression, Anxiety and Stress Scale

    Time frame: immediate post-intervention

Secondary outcomes

  1. Depressive symptoms

    Measured by the depression subscale of the Depression, Anxiety and Stress Scale (DASS). The subscale consists of 7 questions, each responses range from 0 (not applicable) to 3 (the most applicable). The higher score represents more severe depressive symptoms.

    Time frame: 3-month post intervention

  2. Anxiety symptoms

    Measured by the anxiety subscale of the Depression, Anxiety and Stress Scale

    Time frame: 3-month post intervention

07

Study locations

1 of 1 sites recruiting
  • University of Hong Kong
    Hong Kong, 0000, Hong Kong
    • Yi Nam Suen · Contact
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 20, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03751696
Lead sponsor
The University of Hong Kong
Responsible party
Professor Eric Y.H. Chen (Chair Professor, The University of Hong Kong) — Principal investigator
First posted
Nov 23, 2018
Start date
Nov 15, 2018
Primary completion
Sep 30, 2021 (estimated)
Completion
Dec 31, 2021 (estimated)
Last update
Apr 20, 2021

Study contacts

Suen YN, PhD
Contact
suenyn@hku.hk
22554486
Chan Yuk Yu
Contact
vinciyy@connect.hku.hk
22554486
Eric YH Chen, MD
study director · The University of Hong Kong

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion